ReviewMedical oncology (Northwood, London, England)2022

Combination of AURKA inhibitor and HSP90 inhibitor to treat breast cancer with AURKA overexpression and TP53 mutations.

Fuping Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.